The Food and Drug Administration (FDA) has issued an alert to consumers that two outbreak clusters of a gastrointestinal illness known as cyclosporiasis may be associated with raw basil and mesculin/spring mix salad served in Texas and Illinois. The agency is working with the Centers for Disease Control and Prevention (CDC) and state and other health authorities to determine the cause and scope of the problem.
Cyclosporiasis is caused by the ingestion of the Cyclospora parasite and results in the infection of the small intestine. It causes watery diarrhea with frequent, sometimes explosive, bowel movements. Other symptoms include loss of appetite, substantial weight loss, stomach cramps, nausea, vomiting, muscle aches, low-grade fever and fatigue. Symptoms usually develop about a week after consuming the contaminated food. Cyclospora infection can be successfully treated with appropriate antibiotic therapy. Individuals experiencing these symptoms after consuming basil and mesculin/spring mix salad products are advised to consult their physicians and notify their local health departments.
The two outbreak clusters to date are:
-- In February 2004, approximately 57 individuals in Wheaton, Ill. were reported sick after consuming food containing basil and mesculin prepared by a restaurant. Twenty of these cases have been confirmed by laboratory testing to have been stricken with cyclosoriasis.
-- In that same month 38 people in Irving, Texas were also reported ill after eating basil and mesculin mix at a local restaurant. Sixteen of these cases were later confirmed by laboratory testing as cyclosporiasis.
FDA is actively working with the state and local departments in tracing back the potentially contaminated product to determine its source.
Source: FDA
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.